Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
25-NBOMe series
|
| gptkbp:category |
hallucinogens
designer drugs N-benzylphenethylamines serotonergic psychedelics |
| gptkbp:chemicalStructureFeature |
N-benzyl substitution
|
| gptkbp:derivedFrom |
2C family of phenethylamines
|
| gptkbp:discoveredBy |
gptkb:Ralf_Heim
|
| gptkbp:duration |
6-10 hours (varies by compound)
|
| gptkbp:effect |
confusion
nausea vomiting hypertension paranoia psychosis seizures tachycardia hallucinations agitation death (in overdose) vasoconstriction |
| gptkbp:excretion |
kidneys
|
| gptkbp:firstSynthesized |
2003
|
| https://www.w3.org/2000/01/rdf-schema#label |
NBOMe compounds
|
| gptkbp:legalStatus |
controlled substance in many countries
|
| gptkbp:marketedAs |
research chemicals
|
| gptkbp:mechanismOfAction |
5-HT2A receptor agonist
|
| gptkbp:metabolism |
liver
|
| gptkbp:notableEvent |
linked to multiple fatalities
misrepresented as LSD |
| gptkbp:notableMember |
gptkb:25B-NBOMe
gptkb:25C-NBOMe gptkb:25I-NBOMe |
| gptkbp:origin |
gptkb:Germany
|
| gptkbp:relatedTo |
gptkb:phenethylamines
psychedelic phenethylamines |
| gptkbp:routeOfAdministration |
insufflation
sublingual buccal |
| gptkbp:sells |
gptkb:water
powder blotter paper |
| gptkbp:toxicity |
high potential for overdose
|
| gptkbp:usedAs |
psychedelic drugs
|
| gptkbp:bfsParent |
gptkb:Club_Drugs_and_Novel_Psychoactive_Substances
|
| gptkbp:bfsLayer |
8
|